US Life Science Tools & Diagnostics: How is AI changing pharma’s preclinical research activities? (expert webinar takeaways)

Bernstein hosted an October 12 expert webinar with Tom Fleming, co-founder and recent CEO of Arctoris, to discuss how AI is changing preclinical research and the implications for life science tools companies. Key takeaways: demand for new data to train AI models is real and has become mainstream, with large pharma now representing the majority of Arctoris's data-generation business; however, a tenfold to hundredfold increase in data demand may be offset by similarly rapid declines in cost per data point. Instruments generating high-value data at high throughput should benefit most;